• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
8,056.00 221 (2.82%)
  • As on 01 Aug 2026 (EOD)
  • Today’s Low

    7,870.50
  • Today’s High

    8,090.00
  • Open

    7,873.00
  • Perv Close

    7,835.00
  • 52W Low

    5,636.50
  • 52W High

    8,090.00

Key Indicators

  • P/E(TTM)

    80.33

  • Mar.Cap (₹Cr.)

    213,861.49

  • Div & Yield %

    0.37

  • Book Value(₹)

    629.49

  • Debt-Equity Ratio

    2.82

  • AGM Date

    31-Jul-2026

  • EPS

    100.29

  • P/E Ratio

    80.33

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    213,861.49

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    629.50

  • Sales( ₹ in Cr.)

    10,388.00

  • NP (in Cr.)

    2,662.28

  • NP Var(%)

    21.0

  • Div%

    1500.0

  • CPS (₹)

    117.70

  • EPS (₹)

    100.30

  • Traded Value (₹ in Lakhs)

    213,878.74

  • 52 Week High

    8,090.00

  • 52 Week Low

    5,636.50

  • Price BSE

    8057.0

  • Price NSE

    8,056.00

  • Market Capital( in Cr.)

    213,878.74

  • P/C Ratio

    68.50

  • P/E Ratio

    80.30

  • Price Vs.BV

    100.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10,388.00 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61
Other Income 506.00 352.00 337.00 349.00 111.26 62.53
Stock Adjustments 244.00 83.00 127.00 -50.00 449.99 100.00
Total Income 11,138.00 9,633.00 8,129.00 7,924.00 9,441.07 6,961.14
EXPENDITURE :            
Raw Materials 4,339.00 3,827.00 3,270.00 3,035.00 3,499.18 2,416.47
Power and Fuel Cost 530.00 465.00 477.00 496.00 390.05 319.15
Employee Cost 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Other Manufacturing Expenses 325.00 276.00 299.00 285.00 255.38 202.29
Selling and Administration Expenses 509.00 460.00 367.00 402.00 340.16 292.53
Miscellaneous Expenses 114.00 63.00 137.00 55.00 40.95 37.69
Employee Benefit Expenses 1,400.00 1,210.00 1,067.00 953.00 926.55 808.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,217.00 6,301.00 5,617.00 5,226.00 5,452.27 4,076.81
Operating Profit 3,921.00 3,332.00 2,512.00 2,698.00 3,988.80 2,884.33
Interest 24.00 2.00 4.00 2.00 1.73 1.81
Gross Profit 3,897.00 3,330.00 2,508.00 2,696.00 3,987.07 2,882.52
Depreciation 461.00 401.00 376.00 342.00 310.55 254.65
Profit Before Tax 3,436.00 2,929.00 2,132.00 2,354.00 3,676.52 2,627.87
Current Tax 869.00 793.00 511.00 438.00 637.20 609.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -40.00 -73.00 45.00 108.00 90.78 64.10
Reported Net Profit 2,607.00 2,209.00 1,576.00 1,808.00 2,948.54 1,954.72
Extraordinary Items -55.28 0.00 0.74 3.07 -1.65 -2.45
Adjusted Net Profit 2,662.28 2,209.00 1,575.26 1,804.93 2,950.19 1,957.17
Adjustment below Net Profit 6.00 -2.00 -1.00 2.00 2.18 0.16
P & L Balance brought forward 13,357.00 11,725.00 10,922.00 9,967.00 7,588.31 5,814.44
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 604.00 575.00 772.00 855.00 571.50 181.01
P & L Balance carried down 15,366.00 13,357.00 11,725.00 10,922.00 9,967.53 7,588.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,500.00 1,500.00 1,000.00
Dividend Per Share(Rs) 30.00 30.00 30.00 30.00 30.00 20.00
Earnings Per Share-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Earnings Per Share(Adj)-Unit Curr 98.38 83.36 59.47 68.23 111.08 73.64
Book Value 630.60 562.08 508.83 479.43 440.44 349.28
Book Value(Adj)-Unit Curr 630.60 562.08 508.83 479.43 440.44 349.28

Shareholding Pattern

  • Promoter Group

    51.88%

  • Public Share Holding

    48.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 8,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,735,090 48.87 129,735,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,735,090 51.88 137,735,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 4,252 0.00 4,252 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 102,997 0.04 102,997 8
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 53,615,576 20.20 53,615,576 747
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 11,807,841 4.45 11,807,841 25
Mutual Funds / UTI 36,819,982 13.87 36,819,982 46
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,713,982 1.02 2,713,982 34
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 105,064,630 39.58 105,064,630 864
2] Non Institution
Bodies Corporate 3,167,448 1.19 3,167,448 1,400
Clearing Members 543 0.00 543 7
Directors of their Relatives 723,745 0.27 723,745 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,177,961 0.44 1,177,961 9,129
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 282,185 0.11 282,185 3,048
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,286,500 0.48 1,286,500 7
Individuals holding nominal share capital up to Rs. 1 lakh 15,738,973 5.93 15,679,902 211,808
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 261,650 0.10 261,650 41
Others 29,855 0.01 29,855 2
Sub Total 22,668,860 8.54 22,609,789 225,454
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 265,409,509 226,324

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024
  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 8,056.65 10,894.00 10,388.00 82.04 21.38
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77